Skip to main content

Table 2 Hazard ratios and coefficients of DFS-related ARGs

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Gene Hazard ratio 95%CI Coefficient p-value
VAV2 2.50 1.64–3.80 3.3924  < 0.05
NRP1 2.41 1.58–3.70 0.5622
PRG2 2.31 1.51–3.54 1.1902
JAG2 2.13 1.39–3.27 0.3202
LPL 1.85 1.23–2.80 - 0.0801
POSTN 1.77 1.17–2.69 0.3631
FSTL1 1.76 1.17–2.69 0.7902
PF4 1.75 1.14–2.69 0.6997
JAG1 1.75 1.15–2.67 0.2249
COL3A1 1.73 1.14–2.62 0.3681
OLR1 1.65 1.08–2.52 − 0.0198
VEGFA 1.58 1.01–2.49 0.1602
VTN 1.56 1.03–2.36 0.0476
S100A4 1.96 1.17–3.29 0.9752
FGFR1 0.60 0.39–0.92 − 1.1699
LRPAP1 0.59 0.39–0.89 1.1291
CXCL6 0.57 0.37–0.89 − 0.1911
SERPINA5 0.52 0.34–0.78 − 0.4216
APP 0.46 0.30–0.71 − 0.3995
  1. DFS disease-free survival, CI confidence interval, NA not applicable